Comparison of TPMT and NUDT15 polymorphisms in Chinese patients with inflammatory bowel disease

doi:10.3748/wjg.v24.i8.941

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8845)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

678

HTML

5098

Figures (1-3)

271

Tables (1-3)

247

Sum=6294

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1055

Download

1496

Sum=2551

Feb 28, 2018 (publication date) through Dec 26, 2024

Times Cited of This Article

Times Cited (32)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. Feb 28, 2018; 24(8): 941-948
Published online Feb 28, 2018. doi: 10.3748/wjg.v24.i8.941

Table 1 Characteristics of patients

	UC	CD	UIBD	Total
No. of patients (n)	39 (17.8)	176 (80.4)	4 (1.8)	219
Age in yr	42.74 ± 13.60	30.51 ± 11.84	45.25 ± 16.62	33.44 ± 13.08
Sex, M/F	27/12	132/44	1/3	161/59
TPMT genotype
A/A	38 (97.4)	174 (98.9)	4 (100)	216 (98.6)
A/G^a	1 (2.6)	2 (1.1)	0	3 (1.4)
NUDT15 genotype
C/C	31 (79.5)	140 (79.5)	4 (100)	175 (79.9)
C/T	8 (20.5)	36 (20.5)	0	44 (20.1)
AZA therapy	3 (7.7)	77 (43.8)	0	80 (36.5)

Data are presented as n (%) or mean ± SD.

^aP < 0.05 vs NUDT15 C/T. CD: Crohn’s disease; UC: Ulcerative colitis; UIBD: Undetermined inflammatory bowel disease, AZA: Azathioprine.

Table 2 Association analysis of azathioprine and NUDT15 polymorphism

Genotype of *NUDT15*	C/C	C/T	Total	P value
No. of patients (gene frequencies)	64 (90.0)	16 (10.0)	80	-
Age in yr	33.69 ± 11.31	31.13 ± 12.40	33.18 ± 11.50	0.429
Sex, M/F	48/16	11/5	59/21	0.611
Disease stages
Remission	6 (9.4)	3 (18.8)	9 (11.3)	0.253
Mild activity	10 (15.6)	2 (12.5)	12 (15.0)
Moderate activity	35 (54.7)	5 (31.3)	40 (50.0)
Severe activity	13 (20.3)	6 (37.5)	19 (23.8)
Initial dosage of AZA in mg/kg daily	1.044 ± 0.318	1.241 ± 0.252	1.082 ± 0.441	0.596
Duration of AZA in mo	8.1 ± 11.19	9.3 ± 9.95	8.4 ± 10.90	0.686
Combined with corticosteroids	28 (43.8)	5 (31.3)	33 (41.3)	0.071
Combined with IFX	14 (21.9)	7 (43.8)	21 (26.3)
Combined with IFX and corticosteroid	0	1 (6.3)	1 (1.3)
Leukopenia	11 (17.2)	8 (50.0)^a	19 (23.8)	0.006

Data are presented as n (%) or mean ± SD.

^aP < 0.05 vs NUDT15 C/C developed leukopenia. AZA: Azathioprine; IFX: Infliximab.

Table 3 Multivariate association analyses of azathioprine-induced leukopenia

Factor	P value	OR (95%CI)	RR	EF/PF
Age	0.714	-	-	-
Sex, female	0.039	0.146 (0.023-0.909)	0.527	0.124
Disease stages	0.509	-		-
Duration of AZA	0.438	-		-
Combined with corticosteroids	0.023	0.201 (0.050-0.798)	0.437	0.253
Combined with IFX	0.339	-	-	-
Combined with IFX and corticosteroid	1.000	-	-	-
TPMT	1.000	-	-	-
NUDT15	0.004	7.663 (1.893-31.023)	2.909	0.276

Citation: Wang HH, He Y, Wang HX, Liao CL, Peng Y, Tao LJ, Zhang W, Yang HX. Comparison of TPMT and NUDT15 polymorphisms in Chinese patients with inflammatory bowel disease. World J Gastroenterol 2018; 24(8): 941-948
URL: https://www.wjgnet.com/1007-9327/full/v24/i8/941.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i8.941